139 related articles for article (PubMed ID: 20340055)
61. A pilot study of longitudinal serum cytokine and angiogenesis factor levels as markers of therapeutic response and survival in patients with head and neck squamous cell carcinoma.
Druzgal CH; Chen Z; Yeh NT; Thomas GR; Ondrey FG; Duffey DC; Vilela RJ; Ende K; McCullagh L; Rudy SF; Muir C; Herscher LL; Morris JC; Albert PS; Van Waes C
Head Neck; 2005 Sep; 27(9):771-84. PubMed ID: 15920746
[TBL] [Abstract][Full Text] [Related]
62. The over expression of cathelicidin peptide LL37 in head and neck squamous cell carcinoma: the peptide marker for the prognosis of cancer.
Gill K; Mohanti BK; Singh AK; Mishra B; Dey S
Cancer Biomark; 2011-2012; 10(3-4):125-34. PubMed ID: 22674298
[TBL] [Abstract][Full Text] [Related]
63. High serum levels of YKL-40 in patients with squamous cell carcinoma of the head and neck are associated with short survival.
Roslind A; Johansen JS; Christensen IJ; Kiss K; Balslev E; Nielsen DL; Bentzen J; Price PA; Andersen E
Int J Cancer; 2008 Feb; 122(4):857-63. PubMed ID: 17957792
[TBL] [Abstract][Full Text] [Related]
64. The Diagnostic and Prognostic Value of Tumor Markers (CEA, SCC, CYFRA 21-1, TPS) in Head and Neck Cancer Patients.
Barak V; Meirovitz A; Leibovici V; Rachmut J; Peretz T; Eliashar R; Gross M
Anticancer Res; 2015 Oct; 35(10):5519-24. PubMed ID: 26408719
[TBL] [Abstract][Full Text] [Related]
65. Increased prevalence of T(H)17 cells in the peripheral blood of patients with head and neck squamous cell carcinoma.
Li C; Zhao Y; Zhang W; Zhang W
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Jul; 112(1):81-9. PubMed ID: 21458322
[TBL] [Abstract][Full Text] [Related]
66. Stimulated monocyte IL-6 secretion predicts survival of patients with head and neck squamous cell carcinoma.
Heimdal JH; Kross K; Klementsen B; Olofsson J; Aarstad HJ
BMC Cancer; 2008 Jan; 8():34. PubMed ID: 18234094
[TBL] [Abstract][Full Text] [Related]
67. Serum levels of tumor necrosis factor in squamous cell carcinoma of the head and neck.
Soylu L; Ozcan C; Cetik F; Paydaş S; Kiroğlu M; Aydoğan B; Sargin O; Ozşahinoglu C; Seyrek E
Am J Otolaryngol; 1994; 15(4):281-5. PubMed ID: 7978027
[TBL] [Abstract][Full Text] [Related]
68. Health behaviors predict higher interleukin-6 levels among patients newly diagnosed with head and neck squamous cell carcinoma.
Duffy SA; Teknos T; Taylor JM; Fowler KE; Islam M; Wolf GT; McLean S; Ghanem TA; Terrell JE
Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):374-81. PubMed ID: 23300019
[TBL] [Abstract][Full Text] [Related]
69. Higher importance of interleukin 6 than classic tumor markers (carcinoembryonic antigen and squamous cell cancer antigen) in the diagnosis of esophageal cancer patients.
Łukaszewicz-Zając M; Mroczko B; Kozłowski M; Nikliński J; Laudański J; Szmitkowski M
Dis Esophagus; 2012 Apr; 25(3):242-9. PubMed ID: 21895853
[TBL] [Abstract][Full Text] [Related]
70. Arterial spin labeling perfusion-weighted MR imaging: correlation of tumor blood flow with pathological degree of tumor differentiation, clinical stage and nodal metastasis of head and neck squamous cell carcinoma.
Abdel Razek AAK; Nada N
Eur Arch Otorhinolaryngol; 2018 May; 275(5):1301-1307. PubMed ID: 29582174
[TBL] [Abstract][Full Text] [Related]
71. CYFRA 21-1: a suitable tumor marker in patients with head and neck cutaneous squamous cell carcinoma?
Rudhart SA; Schultz JD; Gehrt F; Pavel FL; Birk R; Hoch M; Stuck BA; Hoch S
Eur Arch Otorhinolaryngol; 2019 Dec; 276(12):3467-3475. PubMed ID: 31482332
[TBL] [Abstract][Full Text] [Related]
72. T regulatory type 1 cells in squamous cell carcinoma of the head and neck: mechanisms of suppression and expansion in advanced disease.
Bergmann C; Strauss L; Wang Y; Szczepanski MJ; Lang S; Johnson JT; Whiteside TL
Clin Cancer Res; 2008 Jun; 14(12):3706-15. PubMed ID: 18559587
[TBL] [Abstract][Full Text] [Related]
73. Comparison of Cyfra 21-1 and SCC assays in head and neck tumours.
Banal A; Hacene K; Berthelot-Ruff E; Mahé E; Fontana X; Pichon MF
Tumour Biol; 2001; 22(1):27-35. PubMed ID: 11054024
[TBL] [Abstract][Full Text] [Related]
74. Evaluation of TATI and CYFRA 21-1 in patients with head and neck squamous cell carcinoma.
Goumas PD; Mastronikolis NS; Mastorakou AN; Vassilakos PJ; Nikiforidis GC
ORL J Otorhinolaryngol Relat Spec; 1997; 59(2):106-14. PubMed ID: 9166881
[TBL] [Abstract][Full Text] [Related]
75. Serum cytokine profile of laryngeal squamous cell carcinoma patients.
Sotirović J; Perić A; Vojvodić D; Baletić N; Zaletel I; Stanojević I; Erdoglija M; Milojević M
J Laryngol Otol; 2017 May; 131(5):455-461. PubMed ID: 28294085
[TBL] [Abstract][Full Text] [Related]
76. Peripheral blood neutrophil granulocytes from patients with head and neck squamous cell carcinoma functionally differ from their counterparts in healthy donors.
Trellakis S; Farjah H; Bruderek K; Dumitru CA; Hoffmann TK; Lang S; Brandau S
Int J Immunopathol Pharmacol; 2011; 24(3):683-93. PubMed ID: 21978700
[TBL] [Abstract][Full Text] [Related]
77. Association of IgA-anti-Fab autoantibodies with disease stage in head-and-neck cancer.
Süsal C; Maier H; Lorenz K; Opelz G
Int J Cancer; 1994 Apr; 57(1):47-50. PubMed ID: 8150540
[TBL] [Abstract][Full Text] [Related]
78. Cilengitide and Cetuximab Reduce Cytokine Production and Colony Formation of Head and Neck Squamous Cell Carcinoma Cells
Wichmann G; Cedra S; Schlegel D; Kolb M; Wiegand S; Boehm A; Hofer M; Dietz A
Anticancer Res; 2017 Feb; 37(2):521-527. PubMed ID: 28179297
[TBL] [Abstract][Full Text] [Related]
79. [Effect of tissue inhibitors of metalloproteinases (TIMP) on course and prognosis of head and neck squamous cell carcinoma].
Klisho EV; Kondakova IV; Choĭnzonov EL; Shishkin DA; Cheremisina OV; Chuzhevskaia SIu
Vopr Onkol; 2009; 55(6):717-21. PubMed ID: 20210014
[TBL] [Abstract][Full Text] [Related]
80. Significance of endothelial progenitor cells (EPC) for tumorigenesis of head and neck squamous cell carcinoma (HNSCC): possible marker of tumor progression and neovascularization?
Ziebart T; Blatt S; Günther C; Völxen N; Pabst A; Sagheb K; Kühl S; Lambrecht T
Clin Oral Investig; 2016 Nov; 20(8):2293-2300. PubMed ID: 26993659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
